Yes, there are serious and major obstacles to be overcome in order for CytoDyn to become a success. Many companies receive a RTF from the FDA and maybe Nader and the whole team could have handled the BLA better. But the FDA appears insistent at this time on approving the 700 mg dose for both the combo and monotherapy indications and it's their decision to make.
Market Data 
Markets 
AI
